summarized and calculated the density of CD3+ and CD8+ T cells within the tumor and its invasive margin to define the Immunoscore (IS), which provides a reliable estimate of the risk of recurrence in CRC patients (24). This evidence concerns the gene CD8A and colorectal carcinoma.